Coral Laboratories Limited (BOM:524506)

India flag India · Delayed Price · Currency is INR
422.85
-16.35 (-3.72%)
At close: Jan 21, 2026
-45.79%
Market Cap1.56B
Revenue (ttm)889.77M
Net Income (ttm)173.53M
Shares Out3.57M
EPS (ttm)48.57
PE Ratio8.97
Forward PEn/a
Dividend1.50 (0.34%)
Ex-Dividend DateSep 19, 2025
Volume255
Average Volume1,390
Open415.00
Previous Close439.20
Day's Range415.00 - 440.00
52-Week Range419.00 - 850.90
Beta0.92
RSI43.68
Earnings DateNov 7, 2025

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 197
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524506
Full Company Profile

Financial Performance

In 2024, Coral Laboratories's revenue was 1.15 billion, an increase of 37.47% compared to the previous year's 836.60 million. Earnings were 241.56 million, an increase of 52.99%.

Financial Statements